Over 10 new studies by LBCA SAB members and others focusing on lobular breast cancer are being added to LBCA’s Julia K. Levine ILC Publications Library. Read the individual studies below:
Dr. Patrick Derksen:
- Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage – PMC
Dr. Julia Foldi:
- Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the Breast
Dr. Maxine Jochelson:
- Comparison of Contrast-enhanced Mammography and Low-Energy Imaging with or without Supplemental Whole-Breast US in Breast Cancer Detection | Radiology
Dr. Jason Mouabbi:
- Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ
Dr. Rita Mukhtar:
- Socioeconomic status impacts tumor biology, treatment, and outcomes in over 200,000 patients with invasive lobular carcinoma of the breast: an analysis of the National Cancer Database
Dr. Gary Ulaner:
- 18F-Fluoroestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor–Positive Breast Cancer: A Systematic Review and Metaanalysis ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer – PubMed
- ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer – PubMed
Dr. Matt Sikora:
- Estrogen Receptor co-opts Mediator of DNA Damage Checkpoint 1 (MDC1) to Drive Epigenomic Remodeling and Transcriptional Regulation in ILC Cells
- Targeting DNA Repair Dysfunction in Lobular Breast Cancer by PARP Inhibition
- Genetic E-Cadherin Loss Creates a Distinct Phenotype in an Early ILC Tumorigenesis Model Transcriptomic Analysis of MDC1 as a Novel Coregulator of Estrogen Receptor in ILC | Endocrinology | Oxford Academic